Loading institutional data...
Loading institutional data...
Held by 660 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 633 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $33.13T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $405.3B | 46.3× | 32.2× | 6.0× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $399.8B | 46.8× | — | 8.7× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $298.4B | 44.8× | 21.3× | 3.4× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| ABBNY | $187.8B | 50.7× | 33.5× | 5.8× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $175.3B | 24.7× | 16.7× | 7.2× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $173.5B | 42.8× | — | 6.3× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| DE | $165.5B | 33.1× | — | 3.6× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| HON | $157.6B | 33.7× | 18.9× | 4.2× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| HTHIF | $153.6B | 0.7× | — | 0.0× | 3.9% | 25.2% | 2.6% | 16.6% | 7.4% | — | 2 |
| LMT | $132.3B | 26.9× | 17.0× | 1.8× | 5.6% | 10.2% | 6.7% | 74.6% | 18.4% | 2.4× | 2,807 |
| PH | $127.9B | 36.8× | 28.7× | 6.4× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| HWM | $117.0B | 78.5× | 51.2× | 14.2× | 11.1% | — | 18.3% | 28.2% | 18.4% | 1.2× | 1,399 |
| ADP | $109.5B | 27.1× | — | 5.3× | 7.1% | 46.0% | 19.8% | 65.9% | 40.1% | — | 2,179 |
| TT | $107.8B | 37.3× | 26.5× | 5.1× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $106.3B | 81.5× | 50.3× | 10.4× | 27.7% | 36.3% | 13.0% | 33.8% | 19.5% | 1.4× | 1,748 |
| GD | $103.9B | 24.9× | 18.1× | 2.0× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| PWR | $102.2B | 100.4× | 50.3× | 3.6× | 20.3% | 15.0% | 3.7% | 11.7% | 11.7% | 0.0× | 1,659 |
| JCI | $100.1B | 30.6× | — | 4.2× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| MMM | $96.6B | 30.4× | 18.4× | 3.9× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| CSX | $95.1B | 33.2× | 15.3× | 6.8× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| EMR | $91.4B | 40.2× | — | 5.1× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| UPS | $91.4B | 16.4× | 10.1× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| WM | $90.4B | 33.5× | 12.7× | 3.6× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| CMI | $89.7B | 31.7× | 16.9× | 2.7× | -1.3% | 25.3% | 8.8% | 23.9% | 23.9% | — | 1,877 |
| CRS | $28.4B | 76.9× | 43.5× | 9.8× | 4.3% | 26.7% | 13.1% | 19.9% | 14.6% | 1.1× | 660 |
Peers = companies sharing CRS's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $40M dividends + $102M buybacks = $142M returned.
1 consecutive years of dividend increases · 1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 15%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $316M covers the $55M due within a year 5.7× over. Scheduled principal only (excludes interest & revolver draws). As of 2017-06-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~7.0% on $695M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05
No standout strengths flagged.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 96th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 14.5× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 82.3 | 81.3 | — | — | — | — | — | — |
| Gross Profit | 17.7 | 18.7 | 15.1 | 0.1 | 8.2 | 13.2 | 21.2 | 26.7 |
| R&D | 0.9 | 1.0 | 1.3 | 1.3 | 1.1 | 1.0 | 0.9 | 0.9 |
| SG&A | 8.9 | 8.5 | 9.2 | 12.2 | 9.5 | 8.0 | 8.3 | 8.5 |
| Operating Income | 8.8 | 10.1 | 1.2 | -16.8 | -1.4 | 5.2 | 11.7 | 18.1 |
| Income Tax | -1.3 | 2.1 | 0.2 | -4.6 | -0.8 | 0.6 | 0.9 | 3.2 |
| Net Income | 8.7 | 7.0 | 0.1 | -15.6 | -2.7 | 2.2 | 6.8 | 13.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CRS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.88B 100.0% | $2.76B 100.0% | $2.55B 100.0% | $1.84B 100.0% | $1.48B 100.0% | $2.18B 100.0% | $2.38B 100.0% | $2.16B 100.0% | $1.80B 100.0% | $1.81B 100.0% |
| Cost of Revenue | — | — | — | — | — | — | $1.94B 81.3% | $1.78B 82.3% | $1.50B 83.3% | $1.53B 84.6% |
| Gross Profit | $768.6M 26.7% | $584.3M 21.2% | $337.3M 13.2% | $149.8M 8.2% | $1.0M 0.1% | $329.4M 15.1% | $444.8M 18.7% | $382.3M 17.7% | $300.8M 16.7% | $255.9M 14.1% |
| Research & Development | $26.1M 0.9% | $25.6M 0.9% | $24.4M 1.0% | $20.4M 1.1% | $19.7M 1.3% | $28.0M 1.3% | $23.3M 1.0% | $19.3M 0.9% | $16.9M 0.9% | $16.3M 0.9% |
| Selling, General & Admin | $243.2M 8.5% | $230.2M 8.3% | $204.2M 8.0% | $174.7M 9.5% | $180.2M 12.2% | $201.0M 9.2% | $203.4M 8.5% | $193.0M 8.9% | $176.1M 9.8% | $173.8M 9.6% |
| Operating Income | $521.8M 18.1% | $323.1M 11.7% | $133.1M 5.2% | -$24.9M -1.4% | -$248.6M -16.8% | $25.3M 1.2% | $241.4M 10.1% | $189.3M 8.8% | $121.5M 6.8% | $51.6M 2.8% |
| Interest Expense | $48.4M 1.7% | $51.0M 1.8% | $54.1M 2.1% | $44.9M 2.4% | $32.7M 2.2% | $19.8M 0.9% | $26.0M 1.1% | $28.3M 1.3% | $29.8M 1.7% | $28.0M 1.5% |
| Other Income (Expense), net | -$6.1M -0.2% | -$60.5M -2.2% | -$6.5M -0.3% | $12.7M 0.7% | -$8.4M -0.6% | $600K 0.0% | $600K 0.0% | -$800K -0.0% | -$21.5M -1.2% | -$2.1M -0.1% |
| Pretax Income | $467.3M 16.2% | $211.6M 7.7% | $72.5M 2.8% | -$63.1M -3.4% | -$297.9M -20.2% | $6.1M 0.3% | $216.0M 9.1% | $160.2M 7.4% | $70.2M 3.9% | $21.5M 1.2% |
| Income Tax Expense | $91.3M 3.2% | $25.1M 0.9% | $16.1M 0.6% | -$14.0M -0.8% | -$68.3M -4.6% | $4.6M 0.2% | $49.0M 2.1% | -$28.3M -1.3% | $23.2M 1.3% | $10.2M 0.6% |
| Net Income | $376.0M 13.1% | $186.5M 6.8% | $56.4M 2.2% | -$49.1M -2.7% | -$229.6M -15.6% | $1.5M 0.1% | $167.0M 7.0% | $188.5M 8.7% | $47.0M 2.6% | $11.3M 0.6% |
| Per Share | ||||||||||
| EPS (Basic) | $7.50 | $3.75 | $1.15 | $-1.01 | $-4.76 | $0.02 | $3.46 | $3.96 | $0.99 | $0.23 |
| EPS (Diluted) | $7.42 | $3.70 | $1.14 | $-1.01 | $-4.76 | $0.02 | $3.43 | $3.92 | $0.99 | $0.23 |
| Weighted Avg Shares (Basic) | 50.2M | 49.7M | 48.8M | 48.5M | 48.3M | 48.1M | 47.7M | 47.2M | 47.0M | 48.1M |
| Weighted Avg Shares (Diluted) | 50.7M | 50.3M | 49.2M | 48.5M | 48.3M | 48.2M | 48.1M | 47.6M | 47.1M | 48.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.